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      ABSTRACT 
Purpose: This study evaluated the impact of patient set-up errors on the probability of 
pulmonary and cardiac complications in the irradiation of left-sided breast cancer.  
Methods and Materials: Using the CMS XiO Version 4.6 (CMS Inc., St Louis, MO) 
radiotherapy planning system’s NTCP algorithm and the Lyman –Kutcher-Burman (LKB) 
model, we calculated the DVH indices for the ipsilateral lung and heart and the resultant 
normal tissue complication probabilities (NTCP) for radiation-induced pneumonitis and 
excess cardiac mortality in 12 left-sided breast cancer patients.  
Results: Isocenter shifts in the posterior direction had the greatest effect on the lung V20, 
heart V25, mean and maximum doses to the lung and the heart. Dose volume histograms 
(DVH) results show that the ipsilateral lung V20 tolerance was exceeded in 58% of the 
patients after 1cm posterior shifts. Similarly, the heart V25 tolerance was exceeded after 1cm 
antero-posterior and left-right isocentric shifts in 70% of the patients. The baseline NTCPs 
for radiation-induced pneumonitis ranged from 0.73% - 3.4% with a mean value of 1.7%.  
The maximum reported NTCP for radiation-induced pneumonitis was 5.8% (mean 2.6%) 
after 1cm posterior isocentric shift. The NTCP for excess cardiac mortality were 0 % in 100% 
of the patients (n=12) before and after set-up error simulations.  
Conclusions: Set-up errors in left sided breast cancer patients have a statistically significant 
impact on the Lung NTCPs and DVH indices. However, with a central lung distance of 3cm 
or less (CLD <3cm), and a maximum heart distance of 1.5cm or less (MHD<1.5cm), the 
treatment plans could tolerate set-up errors of up to 1cm without any change in the NTCP to 
the heart.  
Keywords: NTCP, breast cancer radiotherapy, radiation pneumonitis, excess cardiac 
mortality. 
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 INTRODUCTION 
Radiation therapy remains a vital modality in the management of breast cancer patients.  A 
relatively good prognosis is shown in early detected breast cancer patients (1). The need for 
accuracy and precision in targeting the desired volumes is imperative as it not only improves 
success in the treatment but also the normal tissue will be spared. Many factors have been 
investigated that can affect the accuracy of the treatment delivery in breast cancer patients. 
Various researchers reported random or inter-fraction set-up errors of magnitude between 
1.7mm -5.8mm and systematic errors between 1.0mm-14.4mm (2, 3).  
There has been an increase in the reports of radiotherapy induced cardiovascular disease in 
the past 10 years (4). In breast cancer, this increase was stimulated by expert reports of 
radiation induced myocardial infarction, coronary revascularization, or death from ischemic 
heart disease. Darby, Ewertz and McGale, et al (4) suggests that the magnitude of the risk 
after any given dose to the heart is uncertain. A population-based case–control study of 2168 
women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and 
Denmark revealed mean doses to the whole heart of 4.9 Gy (ranging 0.03 to 27.72). Several 
studies have suggested that exposures at this level can cause ischemic heart disease (5, 6, and 
7). In addition to cardiac complications, radiation induced pneumonitis which is one of the 
most significant complications has been reported in breast cancer studies manifesting within 
the period of one to eight months after radiotherapy (10).  
Recent studies have made an effort to estimate the pulmonary and cardiac complication risks 
involved in the radiation treatment of breast cancer. Long term follow-up data and two 
dimensional (2D)-radiographic parameters such as the central lung distance (CLD) and the 
maximum heart distances (MHD) were used to estimate the probability of complications after 
radiotherapy (8, 9 and 10). However, there are controversial reports on the correlation 
  
3 
 
between these radiographic parameters and the published complication probabilities (2, 6, 
and 7). 
With the development of computerized tomography (CT) based planning methods there has 
been an improvement in dose coverage and the ability to calculate relevant dose distributions 
in organs at risk (OAR)(8). The dose volume histograms (DVHs) generated in CT-based 
plans can allow clinicians to use normal tissue complication probabilities (NTCP) models (9, 
10) to estimate the risk of complications in normal organs. The heart and the lungs are among 
the organs that have been most successfully described by NTCP models that are widely 
available today. Many authors have used these NTCP models and parameterisations to 
determine the risk of complications that can arise from different breast cancer treatment 
techniques (6, 11 and 13). Quantec reviews have been helpful as they reported several 
aspects that must be considered when applying NTCP models and dose volume constraints to 
clinical planning (11). The aim of this study was to determine the impact of patient set-up 
errors on the probability of pulmonary and cardiac complications in irradiation of left-sided 
breast cancer. 
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  MATERIALS AND METHODS 
 
Patient selection and treatment planning 
This investigation was carried out using CT data planned using a CMS XiO Version 4.6 
(CMS Inc.,St Louis, MO)  treatment planning system. Twelve left-sided female breast cancer 
patients treated between January 2011 and January 2012 were selected. All treatment plans 
had CT series that were composed of 2.5 mm slices based on the institution breast CT 
simulation protocol. A GE Light speed (GE Medical Systems) CT scanner was used. During 
CT scanning, the radiation oncologist determined the extent of the breast parenchyma, on the 
superior aspect, inferior and the lateral aspect. The planning volumes were determined by 
radio-opaque wires that were used to follow the radiation oncologist’s markings on the 
patient skin.  
The tangential breast plans (no supraclavicular field) were optimized by use of wedges and or 
field in field (FIF) segments.  Appropriate beam weights were applied, 6MV and/or 18 MV 
photon energy was used depending on the breast separation. Multi-leaf collimators (MLC’s) 
were used to shape the radiation fields in order to spare the lung and the heart. The maximum 
allowed central lung distance was 3cm. The maximum amount of the heart allowed in the 
radiation field was 1.5cm. The total prescribed treatment dose was 50Gy delivered in 25 
fractions.  
 
 Delineation of organs at risk (OAR) 
The whole heart and the ipsilateral lung were outlined in all patients. The contoured heart 
volume included the myocardium (heart muscle) and the interior chambers (the left and right 
atrium and the ventricles). The pulmonary trunk, ascending aorta and the superior vena cava 
were not included in the heart volume contoured. The entire OAR volumes were contoured 
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first by the medical dosimetrist and then evaluated by the radiation oncologist. All the plans 
selected for this study were contoured by the same dosimetrist and the same radiation 
oncologist.  
 
 Calculation of the Pulmonary and Cardiac NTCP  
Using the Lyman –Kutcher-Burman (LKB) model, we were able to input the NTCP 
parameters to calculate the pulmonary and cardiac NTCPs. The schematic diagram for the 
NTCP calculations is shown in figure 1. The first objective was to generate dose volume data 
(DVH) for the heart and ipsilateral lung before introducing error shifts on the treatment 
plans. This is the first step in the NTCP calculation flow chart as outlined by Kwa et al (23). 
We had to determine the DVH parameters that would be compared to the ones calculated 
after simulating the set-up errors. The lung DVH parameters for both the heart and the lung 
were taken from the Quantec reviews (14, 16). In regards to heart, for each patient the partial 
volume of the heart receiving more than 25Gy, V25 (cm3) and the mean heart dose were 
obtained. The DVH parameters for the lung recorded include the V20 (cm3) and the mean 
lung dose.  
After recording the baseline NTCPs on the original isocenter, the planning isocenter was 
shifted in the magnitude of 3mm, 5mm, and 10mm in three independent directions(x, y, and 
z) to simulate set- up errors in a method similarly used by Hector et al (18) and Prabhakar et 
al (19). The normal tissue complication probabilities (NTCP) for excess cardiac mortality 
after 10-15 years and pneumonitis was calculated using 2Gy per fraction and the Lyman 
model as described by Burman et al (9).  
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 Selection of Normal tissue complication probability (NTCP) parameters 
In the Quantec reviews, Semenenko and A Li (20) highlighted a difficulty in justifying the 
most accurate parameters for use due to a large number of parameter estimates available in 
literature. The lung NTCP parameters used in this study quoted were based on Semenenko 
and A Li (20) whose study included the lung density corrections. These published Lymen and 
Kutcher model parameters for radiation-induced pneumonitis were based on analysis of 
various multi-institutional toxicity data (15, 21). They reported parameters considering the 
lung both as a single and paired organ. In this study, the following ipsilateral lung parameters 
were used; m = 0.35, n=1 and TD50 = 37.6Gy. The NTCP parameters for calculating excess 
cardiac mortality using the LKB model were based on a study by Canney et al (22) as shown 
in table 1.   
 
Statistical Analysis 
Descriptive statistics (means, medians and range) were used to report the calculated NTCP 
and DVH indices. The difference between the population means for the lung V20 and heart 
V25 DVH indices and the lung NTCP predictions between data with no isocenter shifts and 
the data with various isocenter set-up errors was tested for statistical significance using a 
paired Student’s t-test  comparison. The significance level used was 5% for the two-tailed test 
performed using XLSTAT version 2012.2.02.  
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    RESULTS  
 
The ipsilateral lung (V20), heart (V25) and mean doses. 
The DVH indices for the ipsilateral lung and the heart were calculated before and after the 
set-up error simulations.   
a. DVH indices before the set-up error simulations  
Table 2 shows the ipsilateral lung and heart DVH indices for each patient before set-up error 
simulation (n=12). These values were then used as a baseline for comparison after each set-
up error simulations. The average V20 (n=12) was 16.38Gy (range 10.5-21.8Gy), whereas 
the average mean lung dose delivered to the ipsilateral lung was 8.66Gy (range 5.43-11.6 
Gy). The average V25 value for the heart was 6.3% whereas the mean heart dose was 6.4Gy. 
In one patient, a higher baseline mean heart dose was recorded due to the anatomy of the 
patient, though the maximum lung heart distance was less than 1,5cm.  
 
b. DVH indices after the set-up error simulations  
The DVH indices were analysed again after the set-up error simulations of 0.3cm, 0.5cm 
and 1cm. Tables 4, 5 and 6 shows a comparison between the baseline DVH indices and 
those recorded after the isocentric shifts.  As shown in table 6, the maximum relative change 
in the population mean for the Lung V20 was recorded in the AP shift (16.43Gy to 23.3Gy), 
p<0.0001. Similarly, for the heart, the greatest increase in V25 was in the AP direction after 
1cm shifts (6.26Gy to 12.57Gy), p=0.002.  
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The calculated NTCP values for the Ipsilateral Lung and the Heart. 
NTCP paramaters published by Canney et al (33) (excess cardiac mortality endpoint) and 
Semenenko and A Li (pnemonitis) were used in the calculations (Table 1).  The NTCP for 
the ipsilateral lung and the heart were calculated before and after the set-up error simulations.  
 
a. NTCP calculations before set-up error simulations. 
In addition to the DVH indices that were reported before the isocentre shifts, the NTCP for 
the both the lung and the heart were calculated (table 3). These values show a mean value of 
1.67% (range 0.73-3.4%). A maximum lung NTCP of 3.4 was reported in a patient with 3cm 
central lung distance (CLD). The heart NTCP was 0 for all the patients recruited. All the 
patients had a central lung distance of 3cm or less and an average maximum heart distance 
(MHD) of 1.4cm.  
 
b. NTCP calculations after set-up error simulations. 
Table 7- 9  shows the  population mean for the calculated lung and heart NTCP values before 
and after the 0.3cm, 0.5cm and 1cm  isocenter moves (n=12).  These values were compared 
with the baseline values before the shifts. The relative changes were then quantified as a 
percentage and tested for statistical significance.  Consistent with the DVH indices, the 
maximum calculated population mean NTCP was in the AP direction after a 1cm shift. This 
was a 144% (p<0.001) relative change compared to the value before the shift.  
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DISCUSSION 
Radiation Induced Pneumonitis Complication Probability 
The NTCP data reported in this study for the radiation pneumonitis endpoint are in agreement 
with most published reports of NTCP values ranging from 1-5%. This range is comparable to 
the NTCP recorded in this study before set-up error simulations.  In 67% of the patients 
(n=8), the mean NTCP values were less or equal to 2%. Hurkman (24) reported lower values 
between 0% and 1% using the Lyman- Burman- Kutcher (LKB) Model.  After performing 
set-up error simulations with 0.3cm, 0.5cm and 1cm shifts in the x, y and z directions. The 
maximum percentage variation in NTCP value for the 0.3cm isocenter shift was 78% 
recorded in the anterior –posterior direction. With 0.5cm shifts, the maximum relative NTCP 
was 121.6% recorded in the anterior –posterior direction (p<0.0001). A maximum value of 
144% was recorded with 1cm posterior set-up errors (p<0.001). It is important to note that 
even with the very high percentage differences recorded, the highest absolute maximum 
ipsilateral lung NTCP value recorded was 5.81%. 
 
Excess Cardiac Mortality Complication Probability  
The NTCP for excess cardiac mortality was 0% for all patients. These results are in close 
agreement with O Kyu Noh et al (25) who reported NTCP values for excess cardiac mortality 
of 0.0% in 2-field treatment plans. O Kyu Noh et al (25) also reported an NTCP value of 
0.7% for the three-field plans and 1.7% for the reverse hockey stick techniques using the 
relative seriality model.  Gagliadi et al cautions that NTCP values >5% could jeopardise the 
beneficial effect on survival (14).   
The cardiac NTCP results in this study are in agreement with studies that used the Lyman 
Burman-Kutcher model for reporting cardiac complications. It is evident that set-up errors up 
to 1cm do not have a significant effect on the cardiac NTCP.  Higher NTCP values are 
  
10 
 
reported in studies that used the relative seriality model which is frequently used for assessing 
cardiac mortality and was used by Gagliadi and colleagues (14), who presented clinical data 
on excess cardiac complications in breast cancer and recorded mean NTCP values between 
1.6 and 2.3%. This deviation from our results may be expected since patients Gagliadi and 
colleages were treated for the internal mammary nodes with oblique incident electron or 
photon fields which administered more radiation dose to the heart.   
 
Variation in Pulmonary and Cardiac Dose Volume indices.  
 Graham et al (28) found that the percentage of the ipsilateral lung receiving a dose larger 
than 20Gy was significantly correlated to the grade of pneumonitis. Similarly, the V25 and 
the mean cardiac doses have been used as indicators of cardiac complications in breast 
cancer. In the current research study the DVH indices for both the ipsilateral lung and the 
heart were calculated. 
The Quantec recommend show that the heart V25 should be <10% based on 1% risk of 
cardiac mortality. In addition, the V20 for the ipisilateral lung should be less than 20%. 
However, based on table 6, heart tolerance is exceeded after 1cm anterior-posterior (AP), 
right –left (RL) and left –right (LR) directional moves. The DVH reports also show that 1cm 
posterior shifts caused the greatest deviation in lung tolerance. In 58% of the patients (n=7), 
V20 was out of tolerance based on the Quantec reviews (13, 16). This suggests that errors 
should be strictly kept below 1cm to minimize risk of cardiac complications.  
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Tissue density corrections and choice of algorithms. 
There is need for great caution in comparing the NTCP calculations in treatment planning. 
Gagliadi (14) cautions that if inhomogeneity corrections for the low density lung tissue are 
not made in the treatment plans, the heart dose is underestimated, and this affects the use of 
the NTCP calculations and the volume-based predictions. The lung V20 has been found to be 
sensitive to the choice of the algorithm used.  However, the values for the heart complications 
have been found to be relatively insensitive to the choice of algorithm. The calculation 
algorithm used for treatment plan optimization in this study was the superposition algorithm 
which uses the collapsed cone convolution algorithm and is far more accurate than the 
routinely used FFT convolution in the presence of tissue in homogeneities (15).The current 
investigation made sure that lung NTCP parameters and DVH parameters were from 3D 
conformal studies such as those quoted in the recent Quantec reviews (14, 16). 
 
 
 Clinical Implications  
There is need for radiation oncologists to be aware of the implications of the reported NTCPs 
in left sided breast cancer patients. With improved survival rates in the treatment of breast 
cancer, long term risks of radiotherapy become relevant.  
 It is becoming common in most radiotherapy practices to shape the field with a heart block 
to reduce cardiac exposure. As proposed by Gagliadi et al (6), cardiac risk could be 
substantially reduced by partially blocking the heart using multi-leaf collimators (MLCs) in 
treatment planning. Raj et al (26), recommends that although this is a reasonable method to 
limit cardiac dose, it should be used cautiously especially in inferiorly located tumour beds. 
However, it is crucial to know that the reported NTCPs in this study are for standard 
tangential radiation with 50Gy in 25 fractions. Higher doses and therefore higher risk of 
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complications may be reported for different treatment regimens. For example, Andratschke et 
al (27) reported doses in hypo-fractionation schemes that are higher than the results in this 
study after correction of the fractionation efforts using the linear quadratic model (LQ-
Model) and a/b ratio.  
 
 
Limitations  
The results of this study are based on the LKB model for calculating NTCPs. It could have 
been beneficial to use the relative seriality model for assessing the risk of excess cardiac 
mortality as it has been widely described in literature. CMS XiO V4.16 treatment planning 
only used the LKB NTCP model.  Despite of this limitation, the Quantec reviews reports that 
although the Lyman-Kutcher-Burman model is not considered the best model, it cannot be 
rejected as a good fit of the data (11).  
 
 
 
 
 
 
 
 
 
 
 
 
  
13 
 
CONCLUSIONS 
The simulation of set-up errors in all the 3 directions (x, y, and z) shows that the isocentric 
shifts in the posterior direction have the most significant impact on the DVH data for both the 
lung and the heart. Pulmonary complications could be minimized if overall set-up errors of 
more than 5mm are avoided in any single direction. However, the cardiac NTCPs calculated 
with the standard tangential techniques resulted in zero complication probability for the 
whole heart. 
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Figure 1. Schematic view of the NTCP calculation (adopted from Kwa et al (23) 
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Table 1.  Parameters used for NCTP calculations for the Heart and Lung using the LKB 
model. 
Parameter                                                   OAR 
           _____________________________________________________ 
     Heart     Lung 
D50 (Gy)    48   37.6 
m        0.10   0.35 
n     0.35   1 
a/b ( Gy)    3   3 
Reference volume     Whole heart                          Ipsilateral Lung    
End point   Excess cardiac Mortality         Pneumonitis (Any Grade)  
Reference          Canney et al (33)                     Semenenko and A Li (84) 
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Table 2. Ipsilateral Lung   and Heart DVH indices before set-up error simulations (n=12).  
 
 Patient No.     Lung (V20)     Mean Dose (Gy)               Heart (V25)     Mean heart Dose (Gy)   
    
 
1                10.5                  5.43                                       1.29   2.17 
2  14.6  8.57    3.74  3.34 
3  12.5  6.38    4.99  3.81 
4  12.2  6.49    11  7.21 
5  16.8  8.9    4.21  13.89 
6  17.6  9.34    4.82  4.02 
7  20.45  10    7.28  5.78 
8  20.68  10.37    7.3  6.54 
9  20.35  11.45    8.14  5.58 
10  12.8  6.8    10.2  9.9 
11  21.8  11.6    7.28  5.78 
12  16.8  8.91    7.3  5.5 
Median  16.8  8.9    6.1  5.7 
Mean               16.38  8.66    6.3  6.4   
Range             10.5-21.8     5.43-11.6          1.29-11         2.7-13.89 
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Table 3. The calculated ipsilateral Lung and heart NTCPs before set-up error simulations 
(n=12).  
 
Patient No.      CLD (cm)          Lung NTCP (%)          MHD (cm)         Cardiac NTCP (%)  
1     1.6  0.73    0.9   0 
2   1.8  0.78    1.0   0 
3  2  0.89    1.3   0 
4  2  0.91    1.4   0 
5  2  1.46    1.5   0 
6  2  1.59    1.5   0 
7  2.5  1.81    1.5   0 
8  2.8  1.93    1.5   0 
9  2.9  2.35    1.5   0 
10  3  2.35    1.5   0 
11  3  2.42    1.6   0 
12  3  3.40    1.7   0 
 
Median     2.25  1.59    1.5   0 
Mean  2.38  1.67    1.4   0 
Range   1.6-3  0.73-3.4                                  0.9-1.7           0 
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Table 4. Comparison of volume with 0.3cm isocenter shifts for the heart (V25) and the 
ipsilateral Lung (V20).  
 
 OAR                        No Shift                     0.3cm Shift 
                                 Mean                          Mean                         Relative change (%)        p value 
________________________________________________________________________________ 
                                                                                  
Ipsilateral Lung (V20)     
A-P  16.43   18.9    15.0   0.007 
R-L  16.43   17.7   -25.0   0.001 
L-R  16.43   17.7     7.70   0.001 
S-I  16.43   17.2                4.68   0.001  
I-S  16.43   15.9    -3.47   0.006 
 
 
Heart (V25) 
A-P  6.26   8.24   47    0.003 
R-L  6.26   9.5   31.5   0.082 
L-R  6.26   9.33   51.6   0.003 
S-I  6.26   8.96   37.6   0.004 
I-S  6.26   8.57   37   0.0017 
 
 
 
 
 
  
26 
 
Table 5. Comparison of volume with 0.5cm isocenter shifts for the heart (V25) and the 
ipsilateral Lung (V25).  
 
 OAR                  No Shift                     0.5cm Shift   
                               Mean                        Mean                            Relative change (%)        p value 
________________________________________________________________________________ 
                                                                                  
Ipsilateral Lung     
A-P  16.23   20.93     27.3    0.00015 
R-L  16.23    14.09    -14.2   <0.0001 
L-R  16.23    19.11     16.31   <0.0001 
S-I  16.23   17.78     8.55   0.001 
I-S  16.23   15.89    -5.66   0.004 
  
 
Heart 
A-P  6.26   10.3   60    0.0004 
R-L  6.26   8.23   24     0.14 
L-R  6.26   9.5   52   <0.0001 
S-I  6.26   9.33   49   <0.002 
I-S  6.26   8.23   31.6    0.0046 
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Table 6. Comparison of volume with 1cm isocenter shifts for the heart (V25) and the 
ipsilateral lung (V20).  
 
 OAR          No Shift                  1cm Shift   
                               Mean                         Mean            Relative change (%)              p value 
_________________________________________________________________________________ 
                                                                                  
Ipsilateral Lung     
A-P  16.43   23.3  41.8   <0.0001 
R-L  16.43   11.79  -28   <0.001 
L-R  16.43   21.25  29.3   <0.0001 
S-I  16.43   18.9  15     0.0004 
I-S  16.43   14.19  13.6     0.002 
 
 
Heart 
A-P  6.26   12.57  101.3   0.0002 
R-L  6.26   8.04  28.6   0.311 
L-R  6.26   10.65  70   <0.0001 
S-I  6.26   9.97  59   0.002 
I-S  6.26   7.9  26   0.133 
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Table 7. The populations means for the calculated lung and heart NTCP values before and after 
the 0.3cm isocenter moves (n=12). 
 
 OAR            No Shift                                     0.3cm Shift   
                        _________________           _____________ 
                                  Mean                               Mean                     Relative change (%)        p value     
____________________________________________________________________________________
Ipsilateral Lung     
A-P     1.064    1.90    78   0.007 
R-L   1.064     1.49    40   0.081 
L-R   1.064        2       87.9   0.0005 
S-I   1.064    1.72    61.6   0.064 
I-S   1.064     1.54    44.7   0.768 
 
 
Heart 
    0                           0                             0        0   0 
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Table 8. The populations means for the calculated lung and heart NTCP values before and 
after the 0.5cm isocenter moves (n=12). 
 
 OAR           No Shift                                     0.5cm Shift 
                        _________________           ______________ 
                                  Mean                                Mean                     Relative change (%)        P value     
____________________________________________________________________________________
Ipsilateral Lung     
A-P   1.064   2.36   121.6   <0.0001 
R-L   1.064   1.33   25.0   0.081 
L-R   1.064   2.15   102.1   0.0001 
S-I   1.064   1.84   72.9   0.064 
I-S   1.064   1.5   40.9   0.431 
 
 
Heart 
    0                           0                             0        0   0 
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Table 9. The populations means for the lung and heart NTCP values before and after the 1cm isocenter 
moves (n=12). 
 
 OAR                       No Shift                                 1cm Shift 
                          _________________           ______________ 
                                  Mean                                 Mean                     Relative change (%)        p value     
____________________________________________________________________________________
Ipsilateral Lung     
A-P   1.064   2.6   144   0.001 
R-L   1.064   1.2   127.8   0.0027 
L-R   1.064   2.3   116   0.0001 
S-I   1.064   1.89   77.6   0.0052 
I-S   1.064   1.3   22    0.009 
 
 
Heart 
    0                           0                             0        0   0 
 
 
 
 
 
 
 
 
